Description:
HTT-Q81-PCDNA3.1, PURE, 1-586 (S13,16A)
Repository
|
HD Community Biorepository
|
Quantity |
20 µg |
Quantitation Method |
Please see our FAQ |
Certain Third Party Licensing Requirements |
Invitrogen License for Cat# V790.20 |
Alias
|
Htt-Q81-pcDNA3.1, pure, 1-586 (S13,16A)
|
Family History
|
N
|
Remarks
|
|
Remarks |
DNA corresponding to fragment 1-586 human sequence of the Huntingtin (Htt) containing S13,16A mutation and 81 pure polyglutamine repeats in pcDNA3.1 |
Construct Name |
Htt-Q81-pcDNA3.1, pure, 1-586 (S13,16A) |
Insert Length |
1.8 kb |
Vector |
pcDNA3.1 |
Concentration |
0.322 mg/ml |
Sequence |
ATGGCGACCCTGGAAAAGCTGATGAAGGCCTTCGAGGCCCTCAAGGCCTTCCAGCAGCA GCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGC AGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCA GCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAACAGC CGCCACCGCCGCCGCCGCCGCCGCCGCCTCCTCAGCTTCCTCAGCCGCCGCCGCAGGCA CAGCCGCTGCTGCCTCAGCCGCAGCCGCCCCCGCCGCCGCCCCCGCCGCCACCCGGCCC GGCTGTGGCTGAGGAGCCGCTGCACCGACCAAAGAAAGAACTTTCAGCTACCAAGAAAG ACCGTGTGAATCATTGTCTGACAATATGTGAAAACATAGTGGCACAGTCTGTCAGAAAT TCTCCAGAATTTCAGAAACTTCTGGGCATCGCTATGGAACTTTTTCTGCTGTGCAGTGA TGACGCAGAGTCAGATGTCAGGATGGTGGCTGACGAATGCCTCAACAAAGTTATCAAAG CTTTGATGGATTCTAATCTTCCAAGGTTACAGCTCGAGCTCTATAAGGAAATTAAAAAG AATGGTGCCCCTCGGAGTTTGCGTGCTGCCCTGTGGAGGTTTGCTGAGCTGGCTCACCT GGTTCGGCCTCAGAAATGCAGGCCTTACCTGGTGAACCTTCTGCCGTGCCTGACTCGAA CAAGCAAGAGACCCGAAGAATCAGTCCAGGAGACCTTGGCTGCAGCTGTTCCCAAAATT ATGGCTTCTTTTGGCAATTTTGCAAATGACAATGAAATTAAGGTTTTGTTAAAGGCCTT CATAGCGAACCTGAAGTCAAGCTCCCCCACCATTCGGCGGACAGCGGCTGGATCAGCAG TGAGCATCTGCCAGCACTCAAGAAGGACACAATATTTCTATAGTTGGCTACTAAATGTG CTCTTAGGCTTACTCGTTCCTGTCGAGGATGAACACTCCACTCTGCTGATTCTTGGCGT GCTGCTCACCCTGAGGTATTTGGTGCCCTTGCTGCAGCAGCAGGTCAAGGACACAAGCC TGAAAGGCAGCTTCGGAGTGACAAGGAAAGAAATGGAAGTCTCTCCTTCTGCAGAGCAG CTTGTCCAGGTTTATGAACTGACGTTACATCATACACAGCACCAAGACCACAATGTTGT GACCGGAGCCCTGGAGCTGTTGCAGCAGCTCTTCAGAACGCCTCCACCCGAGCTTCTGC AAACCCTGACCGCAGTCGGGGGCATTGGGCAGCTCACCGCTGCTAAGGAGGAGTCTGGT GGCCGAAGCCGTAGTGGGAGTATTGTGGAACTTATAGCTGGAGGGGGTTCCTCATGCAG CCCTGTCCTTTCAAGAAAACAAAAAGGCAAAGTGCTCTTAGGAGAAGAAGAAGCCTTGG AGGATGACTCTGAATCGAGATCGGATGTCAGCAGCTCTGCCTTAACAGCCTCAGTGAAG GATGAGATCAGTGGAGAGCTGGCTGCTTCTTCAGGGGTTTCCACTCCAGGGTCAGCAGG TCATGACATCATCACAGAACAGCCACGGTCACAGCACACACTGCAGGCGGACTCAGTGG ATCTGGCCAGCTGTGACTTGACAAGCTCTGCCACTGATGGGGATGAGGAGGATATCTTG AGCCACAGCTCCAGCCAGGTCAGCGCCGTCCCATCTGACCCTGCCATGGACCTGAATGA TGGGACCCAGGCCTCGTCGCCCATCAGCGACAGCTCCCAGACCACCACCGAAGGGCCTG ATTCAGCTGTTACCCCTTCAGACAGTTCTGAAATTGTGTTAGACTAA
|
Cloning Information |
Alterations were introduced within an existing Htt-N586-82Q plasmid (obtained from D. Borchelt and described in Tebbenkamp et al, 2012), using site-directed mutagenesis and the QuikChange II XL kit (Stratagene) according to the manufacturer's protocol, except that Stbl2' competent cells (Life Technologies) specifically designed for cloning unstable inserts were used |
Remarks |
DNA corresponding to fragment 1-586 human sequence of the Huntingtin (Htt) containing S13,16A mutation and 81 pure polyglutamine repeats in pcDNA3.1 |
DNA corresponding to fragment 1-586 human sequence of the Huntingtin (Htt) containing S13,16A mutation and 81 pure polyglutamine repeats in pcDNA3.1 |
Remarks |
DNA corresponding to fragment 1-586 human sequence of the Huntingtin (Htt) containing S13,16A mutation and 81 pure polyglutamine repeats in pcDNA3.1 |
PDF |
Vector Map |
|
Plasmid Collection Screening and Propagation |
Supplement |
- |
|